News for the Multiple Sclerosis Community

Teva Terminates Copaxone Trial on PPMS

Reports from Israel state that Teva annouced that it would terminate its trial of Copaxone on primary progressive MS. The trial was supposed to last three years, but interim analysis of the drug is unfavorable.

The story can be found here.